PAUL DUNCAN: Open Payments
NPI 1841852118 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,052 in 68 payments from 9 companies in 2025. Trend: 2023 $16,872 · 2024 $11,177 · 2025 $9,052
Speaker / faculty: $8,125Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $8,592 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $247 |
| Lundbeck LLC | 3 | $50 |
| Indivior Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $36 |
| Almatica Pharma LLC | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Neuronetics, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, ABILIFY ASIMTUFII, REXULTI, LOREEV XR, COBENFY, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across IN — which companies pay providers there.
